BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harper A, Flanagan KL. Effect of sex on vaccination outcomes: important but frequently overlooked. Curr Opin Pharmacol 2018;41:122-7. [PMID: 29883854 DOI: 10.1016/j.coph.2018.05.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gadi N, Wu SC, Spihlman AP, Moulton VR. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses. Front Immunol 2020;11:2147. [PMID: 32983176 DOI: 10.3389/fimmu.2020.02147] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
2 Cox M, Adetifa JU, Noho-Konteh F, Sanyang LC, Drammeh A, Plebanski M, Whittle HC, Rowland-Jones SL, Robertson I, Flanagan KL. Sex-Differential Impact of Human Cytomegalovirus Infection on In Vitro Reactivity to Toll-Like Receptor 2, 4 and 7/8 Stimulation in Gambian Infants. Vaccines (Basel) 2020;8:E407. [PMID: 32707906 DOI: 10.3390/vaccines8030407] [Reference Citation Analysis]
3 Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SC. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Front Immunol 2020;11:579250. [PMID: 33123165 DOI: 10.3389/fimmu.2020.579250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
4 Davitt CJH, Longet S, Albutti A, Aversa V, Nordqvist S, Hackett B, McEntee CP, Rosa M, Coulter IS, Lebens M, Tobias J, Holmgren J, Lavelle EC. Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines. Mucosal Immunol 2019;12:1055-64. [PMID: 30953000 DOI: 10.1038/s41385-019-0159-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Campesi I, Racagni G, Franconi F. Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile? Pharmaceuticals (Basel) 2021;14:730. [PMID: 34451827 DOI: 10.3390/ph14080730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wehbe Z, Hammoud SH, Yassine HM, Fardoun M, El-Yazbi AF, Eid AH. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality. Front Immunol 2021;12:659339. [PMID: 34025658 DOI: 10.3389/fimmu.2021.659339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Macintyre CR, Shaw PJ, Mackie FE, Boros C, Marshall H, Seale H, Kennedy SE, Moa A, Chughtai AA, Trent M, O'loughlin EV, Stormon M. Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine 2019;37:5630-6. [DOI: 10.1016/j.vaccine.2019.07.072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Ami N, Eyal N, Asaf B, Chen A, Adi B, Drorit A, Neta P, Hajar D, Stav R, Eli S. Safety of measles, rubella and mumps vaccines in adults: a prospective cohort study. J Travel Med 2021:taab071. [PMID: 34101817 DOI: 10.1093/jtm/taab071] [Reference Citation Analysis]
9 Bohn-Goldbaum E, Cross T, Leeb A, Peters I, Booy R, Edwards KM. Adverse events following influenza immunization: understanding the role of age and sex interactions. Expert Rev Vaccines 2022;:1-8. [PMID: 34937488 DOI: 10.1080/14760584.2022.2021075] [Reference Citation Analysis]